This inventor holds 12 USPTO granted patents and 49 published patent applications and 2 EPO patents. Top assignees: The University of Texas System, Takeda Pharmaceutical Company Limited. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
12 out of 5,633 
1 out of 1,226 
Years Active: 2020-2026
Title: Katy Rezvani: Innovator in Stem Cell Research and Cancer Treatment
Introduction
Katy Rezvani is a prominent inventor based in Houston, Texas, known for her significant contributions to the field of stem cell research and cancer treatment. With a total of six patents to her name, she has made remarkable strides in developing innovative methods and therapies that harness the potential of mesenchymal stem cells.
Latest Patents
Among her latest patents, one notable invention is the "Methods for production of MSC-derived exosomes." This patent outlines methods for manufacturing clinical-grade exosomes derived from mesenchymal stem cells (MSCs). It also details techniques for loading these exosomes with therapeutic agents, such as siRNA, and methods for treating diseases through the administration of these clinical-grade exosomes. Another significant patent is the "BCMA chimeric antigen receptors and uses thereof." This application provides a BCMA targeting chimeric antigen receptor (CAR) that includes a BCMA binding region and an intracellular costimulatory domain derived from DAP10. It further describes engineered immune effector cells, such as NK cells, that incorporate these chimeric antigen receptors, along with pharmaceutical compositions, kits, and methods for treating cancer.
Career Highlights
Katy Rezvani has worked with esteemed organizations, including the University of Texas System and Takeda Pharmaceutical Company Limited. Her work in these institutions has allowed her to advance her research and contribute to the development of groundbreaking therapies.
Collaborations
Throughout her career, Katy has collaborated with notable colleagues, including Elizabeth J. Shpall and Raghu Kalluri. These collaborations have enriched her research and expanded the impact of her innovations in the medical field.
Conclusion
Katy Rezvani's work exemplifies the intersection of innovation and healthcare, particularly in the realms of stem cell research and cancer treatment. Her patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile